¼¼°èÀÇ ´ÏƼ³î ÀÇ·á±â±â ½ÃÀå
Nitinol Medical Devices
»óǰÄÚµå : 1763233
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 192 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,171,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,515,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ´ÏƼ³î ÀÇ·á±â±â ½ÃÀåÀº 2030³â±îÁö ¹Ì±¹¿¡¼­ 321¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 216¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ´ÏƼ³î ÀÇ·á±â±â ½ÃÀåÀº 2024-2030³â¿¡ CAGR 6.9%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 321¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ´ÏƼ³î ½ºÅÙÆ®´Â CAGR 7.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 116¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ÏƼ³î °¡À̵å¿ÍÀÌ¾î ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ÀÇ CAGR·Î 7.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 60¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ´ÏƼ³î ÀÇ·á±â±â ½ÃÀåÀº 2024³â¿¡ 60¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 49¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 6.3%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 6.6%¿Í 5.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ´ÏƼ³î ÀÇ·á±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

´ÏƼ³î ÀÇ·á±â±â´Â ¹«¾ùÀ̸ç, ¿Ö Çö´ë ÇコÄɾ¼­ Áß¿äÇѰ¡?

´ÏƼ³î ÀÇ·á±â±â´Â ´ÏƼ³î·Î ¸¸µç ÷´Ü ÀÇ·á±â±â ¹× ÀÓÇöõÆ®ÀÔ´Ï´Ù. ´ÏƼ³îÀº ´ÏÄ̰ú ƼŸ´½ÀÇ µ¶Æ¯ÇÑ ÇÕ±ÝÀ¸·Î ¶Ù¾î³­ Çü»ó ±â¾ï·Â, ÃÊź¼º, »ýü ÀûÇÕ¼ºÀ¸·Î À¯¸íÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ ´ÏƼ³î·Î ¸¸µç ±â±¸´Â ´Ù¸¥ ¿Âµµ¿¡ ³ëÃâµÇ¸é ¸ð¾çÀÌ º¯Çϰí, ¿Âµµ°¡ µ¹¾Æ¿À¸é ¿ø·¡ÀÇ ¸ð¾çÀ¸·Î µ¹¾Æ°©´Ï´Ù. ÀÌ ¶§¹®¿¡ ´ÏƼ³îÀº ½ºÅÙÆ®, °¡À̵å¿ÍÀ̾î, Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ®, ÀΰøÇ÷°ü, Ä¡¿­ ±³Á¤±â µî ´Ù¾çÇÑ Àúħ½À¼º ÀÇ·á±â±â¿¡ ÀÌ»óÀûÀÎ ¼ÒÀçÀÔ´Ï´Ù.

´ÏƼ³î ÀÇ·á±â±âÀÇ Á߿伺Àº Ä¡·áÀÇ Á¤È®¼º, À¯¿¬¼º ¹× È¿°ú¸¦ Çâ»ó½ÃŰ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü°è Ä¡·á¿¡¼­ ´ÏƼ³î ½ºÅÙÆ®¿Í °¡À̵å¿ÍÀ̾î´Â º¹ÀâÇÑ Ç÷°ü°è¸¦ ´õ Àß À¯µµÇϰí, Ç÷°ü ³»¿¡¼­ È®ÀåÇÏ¿© Ç÷·ù¸¦ ȸº¹Çϰí, ¸·ÈûÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. Á¤Çü¿Ü°ú ¹× Àç°Ç ¼ö¼ú¿¡¼­ ´ÏƼ³î ÀÓÇöõÆ®´Â »ÀÀÇ Ä¡À¯¿Í °üÀýÀÇ ¾ÈÁ¤¼ºÀ» Áö¿øÇÏ´Â µ¥ ÇÊ¿äÇÑ °­µµ, ź·Â¼º ¹× ÀûÀÀ¼ºÀ» Á¦°øÇÕ´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼ú, ȸº¹ ½Ã°£ ´ÜÃà, ȯÀÚ °á°ú °³¼±¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ´ÏƼ³î ±â¹Ý ±â±â´Â Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀüÀº ´ÏƼ³î ÀÇ·á±â±â ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ´ÏƼ³î ÀÇ·á±â±âÀÇ °³¹ß, ¼º´É ¹× ÀÀ¿ëÀ» Å©°Ô Çâ»ó½ÃÄÑ ´Ù¾çÇÑ ÇコÄÉ¾î ºÐ¾ßÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¹ßÀü Áß Çϳª´Â ·¹ÀÌÀú Àý´Ü, ÀüÇØ ¿¬¸¶, ¿­Ã³¸® µî ´ÏƼ³î °¡°ø ±â¼úÀÇ Çâ»óÀ¸·Î º¸´Ù ³ôÀº ǰÁú, ³ôÀº Á¤¹Ðµµ, ±ä ¼ö¸íÀ» °¡Áø ±â±â°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Á¶ ±â¼úÀÇ Çâ»óÀ¸·Î Á¤±³ÇÑ Ä¡¼ö¿Í ¾ÈÁ¤ÀûÀÎ ¼º´ÉÀ» °®Ãá º¹ÀâÇÑ ±â±¸ ¼³°èÀÇ Á¦Á¶°¡ °¡´ÉÇØÁ® ´ÏƼ³î ±â±¸´Â ÀÇ»ç¿Í ȯÀÚ ¸ðµÎ¿¡°Ô ´õ¿í È¿°úÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ±â±â°¡ µÇ¾ú½À´Ï´Ù.

÷´Ü ÄÚÆÃ ¹× Ç¥¸é °³Áú °³¹ß·Î ´ÏƼ³î ±â±âÀÇ ¾ÈÀü¼º°ú »ýü ÀûÇÕ¼ºÀÌ ´õ¿í Çâ»óµÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î Ç×Ç÷Àü ÄÚÆÃÀº ´ÏƼ³î ½ºÅÙÆ® ¹× ÀΰøÇ÷°üÀÇ Ç÷Àü Çü¼º À§ÇèÀ» °¨¼Ò½Ã۰í, °¡À̵å¿ÍÀ̾ Ä£¼ö¼º ÄÚÆÃÀº ±â±âÀÇ À±È°¼ºÀ» Çâ»ó½ÃÄÑ Ç÷°ü ³»¿¡¼­ÀÇ ¿øÈ°ÇÑ À̵¿À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÄÚÆÃÀº ´ÏƼ³î ±â±âÀÇ Àü¹ÝÀûÀÎ ¼º´ÉÀ» Çâ»ó½ÃÄÑ Àå±âÀûÀÎ À̽Ŀ¡ ÀûÇÕÇϰí À̹°Áú ¹ÝÀÀ°ú °ü·ÃµÈ ÇÕº´ÁõÀ» ÁÙÀÔ´Ï´Ù.

ÃÖ¼Ò Ä§½À ¼ö¼ú ±â¹ýÀÇ ¹ßÀüÀ¸·Î ´ÏƼ³î ÀÇ·á±â±âÀÇ ÀÀ¿ë ¹üÀ§µµ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ´ÏƼ³îÀÇ ÃÊź¼º ¹× Çü»ó±â¾ï Ư¼ºÀ¸·Î ÀÎÇØ Ä«Å×Å͸¦ ÀÌ¿ëÇÑ ÁßÀç½Ã¼ú, Ç÷°ü³» ¼öº¹ ¹× º¹°­°æ ¼ö¼ú¿¡ ´ÏƼ³îÀÇ »ç¿ëÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ´ÏƼ³î ½ºÅÙÆ®³ª ´ëÁ¤¸Æ ÇÊÅÍ´Â Àü´ÞÀ» À§ÇØ ¾ÐÃàµÈ ÈÄ Ç÷°ü ³»¿¡¼­ Á¤È®ÇÏ°Ô È®ÀåµÇ¾î Ç÷·ù¸¦ ȸº¹Çϰųª Ç÷ÀüÀ» Æ÷ȹÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ´ú ħ½ÀÀûÀ̰í, ´õ È¿À²ÀûÀ̸ç, ȯÀÚ Ä£È­ÀûÀÎ Ä¡·á¸¦ Ãß±¸ÇÏ´Â ±¤¹üÀ§ÇÑ Ãß¼¼¿Í ÀÏÄ¡Çϸç, ±Þ¼º ¹× ¸¸¼ºÁúȯÀÇ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ ´ÏƼ³î ÀÇ·á±â±âÀÇ »õ·Î¿î Àû¿ë »ç·Ê´Â?

´ÏƼ³î ÀÇ·á±â±â´Â Àúħ½ÀÀû Ä¡·á¿¡¼­ À¯¿¬¼º, ³»±¸¼º, »ýüÀûÇÕ¼º ¼Ö·ç¼ÇÀÇ Çʿ伺À¸·Î ÀÎÇØ ´Ù¾çÇÑ ÀÇ·áºÐ¾ß¿¡¼­ Ȱ¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü Ä¡·á¿¡¼­´Â °ü»óµ¿¸ÆÁúȯ, ¸»Ãʵ¿¸ÆÁúȯ, Á¤¸ÆÇ÷Àü»öÀüÁõ µîÀÇ Ä¡·á¿¡ ½ºÅÙÆ®, °¡À̵å¿ÍÀ̾î, »öÀü¹æÁöÀåºñ µî ´ÏƼ³î ±â¹Ý Àåºñ°¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃÊź¼º Ư¼ºÀ» °¡Áø ´ÏƼ³î ½ºÅÙÆ®´Â Ç÷°ü ¸ð¾ç¿¡ ¸ÂÃß¾î °³Á¸¼ºÀ» À¯ÁöÇÏ¿© µ¿¸Æ°ú Á¤¸ÆÀÇ Ç÷·ù ȸº¹¿¡ ÇʼöÀûÀÔ´Ï´Ù. ´ÏƼ³î °¡À̵å¿ÍÀ̾î´Â ±¼°îÁø Ç÷°ü °æ·Î¸¦ Ž»öÇÒ ¶§ Á¶ÀÛ¼º°ú ÁöÁö·ÂÀ» Çâ»ó½ÃÄÑ Ç÷°ü ¼ºÇü¼ú ¹× ±âŸ Ç÷°ü ÁßÀç¼ú½Ã ±â±¸¸¦ Á¤È®ÇÏ°Ô Àü´ÞÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù.

Á¤Çü¿Ü°ú ºÐ¾ß¿¡¼­ ´ÏƼ³îÀº »À °íÁ¤, °üÀý ¾ÈÁ¤È­ ¹× ôÃß ±³Á¤¿ë ÀÓÇöõÆ®¿¡ »ç¿ëµË´Ï´Ù. ´ÏƼ³îÀÇ ¾ÐÃà ½ºÅ×ÀÌÇðú °ñÆÇÀº À¯¿¬Çϸ鼭µµ °­·ÂÇÑ ÁöÁö·ÂÀ» Á¦°øÇÏ¿© Ä¡À¯ ¼Óµµ¸¦ ³ôÀ̰í ÀÓÇöõÆ® ½ÇÆÐÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ôÃß ¼ö¼ú¿¡¼­ ´ÏƼ³îÀÇ ·Îµå¿Í ÄÉÀÌÁö°¡ µ¿Àû ¾ÈÁ¤È­¸¦ Á¦°øÇÏ¿© ôÃßÀÇ ¿òÁ÷ÀÓ¿¡ ÀûÀÀÇϸ鼭 Á¤·Ä°ú ÁöÁö·ÂÀ» À¯ÁöÇÕ´Ï´Ù. ´ÏƼ³î ±â±¸´Â ½ÅüÀÇ ¿òÁ÷ÀÓ¿¡ ÀûÀÀÇÏ°í º¯ÇüµÈ ÈÄ¿¡µµ ¿ø·¡ ¸ð¾çÀ¸·Î µ¹¾Æ°¥ ¼ö ÀÖÀ¸¹Ç·Î À¯¿¬¼º°ú ³»±¸¼ºÀÌ ÇʼöÀûÀÎ ±Ù°ñ°Ý°è ÁúȯÀÇ Ä¡·á¿¡ ƯÈ÷ È¿°úÀûÀÔ´Ï´Ù.

½Å°æÇ÷°ü ÁßÀç¼ú¿¡¼­ ´ÏƼ³î ±â±â´Â µ¿¸Æ·ù, ³úÁ¹Áß ¹× ±âŸ ³ú Ç÷°ü ÀÌ»óÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ´ÏƼ³î ÄÚÀϰú À¯·® Àüȯ±â´Â µ¿¸Æ·ù¸¦ Á¤È®ÇÏ°Ô »öÀüÇÏ¿© ÆÄ¿­ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ¸¶Âù°¡Áö·Î ±â°èÀû Ç÷Àü Á¦°Å¼ú¿¡ »ç¿ëµÇ´Â ´ÏƼ³î Ç÷Àü ȸ¼ö ±â±¸´Â ÁÖº¯ Á¶Á÷ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϸ鼭 Ç÷ÀüÀ» ºü¸£°í È¿°úÀûÀ¸·Î Á¦°ÅÇÒ ¼ö ÀÖÀ¸¸ç, ±Þ¼º ÇãÇ÷¼º ³úÁ¹Áß °ü¸®ÀÇ Ç¥ÁØ Ä¡·á¹ýÀ¸·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ´ÏƼ³î ±â±âÀÇ Àû¿ëÀÌ ÀÌ·¯ÇÑ ÀÇ·á Àü¹® ºÐ¾ß·Î È®´ëµÇ°í ÀÖ´Â °ÍÀº ´ÏƼ³î ±â±â°¡ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ȸº¹ ½Ã°£À» ´ÜÃàÇÏ´Â ÃÖ¼Ò Ä§½ÀÀûÀ̰í Á¤¹ÐÇÑ Ä¡·á¸¦ Áö¿øÇÏ´Â µ¥ ÀÖÀ¸¸ç, Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

´ÏƼ³î ÀÇ·á±â±â ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

´ÏƼ³î ÀÇ·á±â±â ½ÃÀåÀÇ ¼ºÀåÀº ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ Ã¤Åà Áõ°¡, ½ÉÇ÷°ü Áúȯ ¹× Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á±â±â ±â¼ú ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ¼¼°è°¡ ÃÖ¼Òħ½À ¼ö¼ú·Î ÀüȯÇϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼úÀº ÀÔ¿ø ±â°£ ´ÜÃà, ÅëÁõ °¨¼Ò, ºü¸¥ ȸº¹, Àüü ÀÇ·áºñ Àý°¨ µîÀÇ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ´ÏƼ³îÀº Çü»ó±â¾ï°ú ÃÊź¼ºÀ» Æ÷ÇÔÇÑ µ¶Æ¯ÇÑ Æ¯¼ºÀ» °¡Áö°í ÀÖÀ¸¸ç, À¯¿¬¼º, ³»±¸¼º, Àü°³½Ã Á¤È®¼ºÀÌ ¿ä±¸µÇ´Â ÃÖ¼Òħ½ÀÀû Àåºñ¿¡ ¸Å¿ì ÀûÇÕÇÕ´Ï´Ù.

½ÉÇ÷°ü Áúȯ, ¸»Ãʵ¿¸Æ Áúȯ ¹× Á¤¸Æ ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ´ÏƼ³î ±â¹Ý ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü°è °³ÀÔÀÌ Ä«Å×Å͸¦ ÀÌ¿ëÇÑ ½Ã¼ú¿¡ ÀÇÁ¸ÇÏ°Ô µÇ¸é¼­ ´ÏƼ³î ½ºÅÙÆ®, °¡À̵å¿ÍÀ̾î, ÇÊÅÍ´Â Æó»ö Ä¡·á, Ç÷Àü °ü¸®, Ç÷°ü ±¸Á¶¹° ÁöÁö µî¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ´ÏƼ³î Àåºñ´Â ¿ªµ¿ÀûÀÎ Ç÷°ü ȯ°æ¿¡ ÀûÀÀÇÒ ¼ö ÀÖ°í Àå±âÀûÀ¸·Î ±â´ÉÀ» À¯ÁöÇÒ ¼ö ÀÖÀ¸¹Ç·Î ÁßÀçÀû ½ÉÀå Àü¹®ÀÇ¿Í Ç÷°ü ¿Ü°ú ÀÇ»çµéÀÌ ¼±È£ÇÏ´Â Á¦Ç°ÀÔ´Ï´Ù.

±â±¸ ¼³°è, Àç·á °úÇÐ ¹× Á¦Á¶ °øÁ¤ÀÇ ¹ßÀüÀº ´ÏƼ³î ±â±âÀÇ ¼º´É°ú ½Å·Ú¼ºÀ» Çâ»ó½ÃÅ´À¸·Î½á ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. »ýü ÀûÇÕ¼ºÀ» ³ôÀ̰í, ¸¶ÂûÀ» ÁÙÀ̰í, Àü´Þ ½Ã½ºÅÛÀ» ÃÖÀûÈ­ÇÑ Â÷¼¼´ë ½ºÅÙÆ®, »öÀü ¹æÁö Àåºñ, Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ®ÀÇ °³¹ß·Î ´Ù¾çÇÑ ÀÇ·á ½Ã¼ú¿¡ ´ÏƼ³î ±â±âÀÇ »ç¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ´ÏƼ³î ±â¹Ý Ç÷°ü³» ÀÌ½ÄÆí°ú ½Å°æÇ÷°ü ½ºÅÙÆ®ÀÇ Çõ½ÅÀº °¢°¢ ´ëµ¿¸Æ·ù¿Í ³úµ¿¸Æ·ù Ä¡·á¸¦ °³¼±ÇÏ¿© ´õ ³ªÀº ÀÓ»ó °á°ú¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

Á¤ºÎ Áö¿ø, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ ¹× À¯¸®ÇÑ »óȯ Á¤Ã¥µµ ´ÏƼ³î ÀÇ·á±â±âÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹Àº ƯÈ÷ ȯÀÚ °á°ú °³¼±ÀÌ Áß¿äÇÑ ½ÉÇ÷°ü ¹× ½Å°æÇ÷°ü ÁßÀç¼ú°ú °°Àº ºÐ¾ß¿¡¼­ ´ÏƼ³î ±â¹ÝÀÇ Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ½ÂÀÎÀ» ½Å¼ÓÈ÷ ½ÂÀÎÇϰí ÀÖ½À´Ï´Ù. Àúħ½ÀÀû Ä¡·á ¹× Àå±â ÀÓÇöõÆ®¿¡ ´ëÇÑ º¸Çè±Þ¿© Á¤Ã¥Àº º´¿ø°ú ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀÌ ´ÏƼ³î ±â¹Ý ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, ¼±Áø±¹°ú ½ÅÈï ½ÃÀå ¸ðµÎ¿¡¼­ ´ÏƼ³î ±â¹Ý ±â¼úÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

Àç·á°úÇÐ, ±â±â ¼³°è ¹× ÃÖ¼Òħ½À ±â¼úÀÇ ¹ßÀüÀ¸·Î ´ÏƼ³î ÀÇ·á±â±â ½ÃÀåÀº °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¿Í ÀÇ·á Àü¹® ºÐ¾ß Àü¹Ý¿¡ °ÉÃÄ À¯¿¬¼º, ³»±¸¼º, »ýüÀûÇÕ¼ºÀ» °®Ãá ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ´ÏƼ³î ÀÇ·á±â±â´Â ȯÀÚ Ä¡·á °á°ú¿Í »îÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇÑ Çö´ë ÀÇ·á Àü·«¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(Á¤Çü¿Ü°ú, Ç÷°ü, Ä¡°ú, ¼ÒÈ­±â, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ±âŸ ÃÖÁ¾ ¿ëµµ), Á¦Ç° À¯Çü(´ÏƼ³î ½ºÅÙÆ®, ´ÏƼ³î °¡À̵å¿ÍÀ̾î, ´ÏƼ³î ÇÊÅÍ, ´ÏƼ³î ¹Ù½ºÄÏ, ´ÏƼ³î Ä«Å×ÅÍ, ±âŸ Á¦Ç° À¯Çü)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Nitinol Medical Devices Market to Reach US$32.1 Billion by 2030

The global market for Nitinol Medical Devices estimated at US$21.6 Billion in the year 2024, is expected to reach US$32.1 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Nitinol Stents, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the analysis period. Growth in the Nitinol Guidewires segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.0 Billion While China is Forecast to Grow at 6.3% CAGR

The Nitinol Medical Devices market in the U.S. is estimated at US$6.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Nitinol Medical Devices Market - Key Trends & Drivers Summarized

What Are Nitinol Medical Devices, and Why Are They So Crucial in Modern Healthcare?

Nitinol medical devices are advanced medical tools and implants made from nitinol, a unique alloy of nickel and titanium known for its exceptional shape memory, superelasticity, and biocompatibility. These properties allow nitinol devices to change shape when exposed to different temperatures and return to their original form once the temperature changes back. This makes nitinol an ideal material for various minimally invasive medical devices, including stents, guidewires, orthopedic implants, vascular grafts, and dental braces.

The importance of nitinol medical devices lies in their ability to enhance the precision, flexibility, and effectiveness of medical treatments. In cardiovascular procedures, nitinol stents and guidewires provide better navigation through complex vasculature and expand within blood vessels to restore blood flow, reducing the risk of blockages. In orthopedic and reconstructive surgeries, nitinol implants offer the strength, elasticity, and adaptability needed to support bone healing and joint stability. With increasing emphasis on minimally invasive surgeries, shorter recovery times, and improved patient outcomes, nitinol-based devices have become essential components in modern healthcare.

How Are Technological Advancements Shaping the Nitinol Medical Devices Market?

Technological advancements have significantly enhanced the development, performance, and application of nitinol medical devices, driving innovation across various healthcare sectors. One of the major advancements is the improvement in nitinol processing techniques, such as laser cutting, electropolishing, and thermal treatment, which have resulted in higher-quality, more precise, and longer-lasting devices. These manufacturing enhancements allow for the production of complex device designs with refined dimensions and consistent performance, making nitinol devices more effective and reliable for both doctors and patients.

The development of advanced coatings and surface modifications has further improved the safety and biocompatibility of nitinol devices. Anti-thrombogenic coatings, for instance, reduce the risk of blood clot formation on nitinol stents and vascular grafts, while hydrophilic coatings on guidewires improve device lubricity, allowing for smoother navigation through vessels. These coatings enhance the overall performance of nitinol devices, making them suitable for long-term implantation and reducing complications related to foreign body reactions.

Advancements in minimally invasive surgical techniques have also expanded the application of nitinol medical devices. The use of nitinol in catheter-based interventions, endovascular repairs, and laparoscopic surgeries has been driven by its superelasticity and shape memory, which allow devices to be delivered in compressed forms through small incisions and then deployed to their functional shapes within the body. For example, nitinol stents and vena cava filters can be compressed for delivery and then expand precisely within vessels to restore blood flow or capture blood clots. These innovations align with broader trends toward less invasive, more efficient, and patient-friendly medical treatments, supporting improved outcomes in both acute and chronic conditions.

What Are the Emerging Applications of Nitinol Medical Devices Across Different Medical Specialties?

Nitinol medical devices are finding expanding applications across various medical specialties, driven by the need for flexible, durable, and biocompatible solutions in minimally invasive treatments. In cardiovascular care, nitinol-based devices like stents, guidewires, and embolic protection devices are widely used to treat conditions such as coronary artery disease, peripheral artery disease, and venous thromboembolism. Nitinol stents, with their superelastic properties, conform to the shape of blood vessels and maintain patency, making them critical for restoring blood flow in arteries and veins. Nitinol guidewires provide enhanced maneuverability and support in navigating tortuous vascular pathways, enabling precise delivery of devices during angioplasty and other vascular interventions.

In the orthopedic sector, nitinol is used in implants for bone fixation, joint stabilization, and spinal correction. Nitinol compression staples and bone plates offer flexible yet strong support, facilitating faster healing and reducing the risk of implant failure. In spinal surgery, nitinol rods and cages provide dynamic stabilization, adapting to spinal movements while maintaining alignment and support. The ability of nitinol devices to adapt to the body’s movements and return to their original shapes after deformation makes them particularly effective in treating musculoskeletal conditions, where flexibility and durability are essential.

In neurovascular interventions, nitinol devices are used to treat aneurysms, strokes, and other vascular abnormalities in the brain. Nitinol coils and flow diverters provide precise embolization of aneurysms, reducing the risk of rupture. Similarly, nitinol clot retrieval devices, used in mechanical thrombectomy procedures, have become standard care for acute ischemic stroke management, as they offer fast and effective clot removal with minimal disruption to surrounding tissues. The expanding applications of nitinol devices across these medical specialties highlight their critical role in supporting minimally invasive, high-precision treatments that enhance patient outcomes and reduce recovery times.

What Drives Growth in the Nitinol Medical Devices Market?

The growth in the nitinol medical devices market is driven by several factors, including increasing adoption of minimally invasive procedures, rising prevalence of cardiovascular and orthopedic conditions, and advancements in medical device technology. One of the primary growth drivers is the global shift toward minimally invasive surgeries, which offer benefits such as shorter hospital stays, reduced pain, quicker recovery, and lower overall healthcare costs. Nitinol’s unique properties, including shape memory and superelasticity, make it highly suitable for minimally invasive devices that require flexibility, durability, and precision during deployment.

The rising prevalence of cardiovascular diseases, peripheral artery disease, and venous disorders has further fueled demand for nitinol-based devices. As cardiovascular interventions increasingly rely on catheter-based techniques, nitinol stents, guidewires, and filters have become essential for treating blockages, managing blood clots, and supporting vascular structures. The ability of nitinol devices to adapt to dynamic vascular environments and maintain long-term functionality has made them a preferred choice among interventional cardiologists and vascular surgeons.

Advancements in device design, materials science, and manufacturing processes have also contributed to market growth by improving the performance and reliability of nitinol devices. The development of next-generation stents, embolic protection devices, and orthopedic implants with enhanced biocompatibility, reduced friction, and optimized delivery systems has expanded their use across diverse medical procedures. For instance, innovations in nitinol-based endovascular grafts and neurovascular stents have improved the treatment of aortic aneurysms and cerebral aneurysms, respectively, supporting better clinical outcomes.

Government support, regulatory approvals, and favorable reimbursement policies have also played a significant role in driving the adoption of nitinol medical devices. Regulatory agencies have expedited approvals for innovative nitinol-based solutions, especially in areas like cardiovascular and neurovascular interventions, where improved patient outcomes are critical. Reimbursement policies for minimally invasive treatments and long-term implants have further encouraged hospitals and healthcare providers to invest in nitinol-based technologies, supporting broader adoption in both developed and emerging markets.

With ongoing advancements in materials science, device design, and minimally invasive techniques, the nitinol medical devices market is poised for robust growth. These trends, combined with increasing demand for flexible, durable, and biocompatible devices across medical specialties, make nitinol medical devices a vital component of modern healthcare strategies aimed at improving patient outcomes and quality of life.

SCOPE OF STUDY:

The report analyzes the Nitinol Medical Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Orthopedic, Vascular, Dental, Gastroenterology, Other Applications); End-Use (Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Uses); Product Type (Nitinol Stents, Nitinol Guidewires, Nitinol Filters, Nitinol Basket, Nitinol Catheters, Other Product Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â